GWAS |
- Adventurousness ( 30643258)
- Adverse response to drug ( 30420678)
- Aging ( 19367585)
- Asthma (childhood onset) ( 27611488)
- Blood pressure (smoking interaction) ( 25189868)
- Body mass index ( 28892062 25673413 20935630)
- Cerebellum white matter volume ( 31530798)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Cognitive performance (processing speed) ( 31598132)
- Congenital heart disease (inherited effect) ( 28468790)
- Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes ( 29221444)
- Coronary artery calcified atherosclerotic plaque score in type 2 diabetes ( 29221444)
- Diffusing capacity of carbon monoxide ( 30694715)
- Diisocyanate-induced asthma ( 25918132)
- Erectile dysfunction and prostate cancer treatment ( 20932654)
- Estimated glomerular filtration rate ( 31217584)
- Facial attractiveness (male raters) ( 30946739)
- General risk tolerance (MTAG) ( 30643258)
- Glomerular filtration rate in chronic kidney disease ( 26420894)
- Hepcidin/ferritin ratio ( 27846281)
- Household income (MTAG) ( 31844048)
- Influenza A (H1N1) infection ( 26379185)
- Lung adenocarcinoma ( 28604730)
- Menarche (age at onset) ( 21102462 25231870)
- Mood instability ( 31168069)
- Motion sickness ( 25628336)
- Night sleep phenotypes ( 27126917)
- Number of sexual partners ( 30643258)
- Optic nerve measurement (disc area) ( 20395239)
- Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma ( 29551627)
- Periodontitis (CDC/AAP) ( 24024966)
- Post bronchodilator FEV1 ( 26634245)
- Severe influenza A (H1N1) infection ( 26379185)
- Type 2 diabetes ( 30130595)
|
- Cerebrospinal fluid α-synuclein levels ( 29959729)
- Longitudinal change in brain amyloid plaque burden ( 26268530)
- Spatial processing ( 31596458)
|